4.6 Article

Novel Role of Long Non-Coding RNA ASAP1-IT1 in Progression of Hepatocellular Carcinoma

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

miR-221-3p regulates hepatocellular carcinoma cell proliferation, migration and invasion via targeting LIFR

Wei Tan et al.

Summary: In this study, miR-221-3p was identified as an oncogene in HCC cells, promoting HCC cell viability and motility by targeting LIFR.

ANNALS OF HEPATOLOGY (2022)

Article Biochemistry & Molecular Biology

Construction and evaluation of a prognosis lncRNA model for hepatocellular carcinoma

Fulei Li et al.

Summary: Research has shown aberrant expression of lncRNA in hepatocellular carcinoma (HCC) and a multi-lncRNA signal was constructed to improve prognosis in HCC. The 12-lncRNA signature was significantly associated with overall survival (OS) in both the training and verification datasets, showing promising potential for prognosis prediction in HCC. Genes related to tumor pathways were found to be highly expressed in the high-risk group based on lncRNA risk scores, suggesting a potential link to HCC progression.

JOURNAL OF CELLULAR BIOCHEMISTRY (2021)

Article Biochemistry & Molecular Biology

An RNA-RNA crosstalk network involving HMGB1 and RICTOR facilitates hepatocellular carcinoma tumorigenesis by promoting glutamine metabolism and impedes immunotherapy by PD-L1+exosomes activity

Yanping Wei et al.

Summary: The study identified potential HMGB1-driven RNA-RNA crosstalk networks in HCC and explored their roles at different stages of the disease, suggesting the potential for RNA-based precision therapy. Interventions against HMGB1 and RICTOR in HCC cells demonstrated the potential to enhance the effectiveness of immunotherapy.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Gastroenterology & Hepatology

Epidemiology and surveillance for hepatocellular carcinoma: New trends

Amit G. Singal et al.

JOURNAL OF HEPATOLOGY (2020)

Review Gastroenterology & Hepatology

Advances in resection and transplantation for hepatocellular carcinoma

Eric Vibert et al.

JOURNAL OF HEPATOLOGY (2020)

Review Biochemistry & Molecular Biology

Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA

Pan Wu et al.

MOLECULAR CANCER (2020)

Review Biochemistry & Molecular Biology

Immune-based therapies for hepatocellular carcinoma

David J. Pinato et al.

ONCOGENE (2020)

Article Medicine, Research & Experimental

LncRNA ASAP1-IT1 positively modulates the development of cholangiocarcinoma via hedgehog signaling pathway

Linqi Guo et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Peter R. Galle et al.

JOURNAL OF HEPATOLOGY (2018)

Article Medicine, Research & Experimental

Diagnostic and prognostic value of circulating lncRNA H19 in gastric cancer

Ebru Esin Yoruker et al.

BIOMEDICAL REPORTS (2018)

Article Gastroenterology & Hepatology

MicroRNA-221 governs tumor suppressor HDAC6 to potentiate malignant progression of liver cancer

Hyun Jin Bae et al.

JOURNAL OF HEPATOLOGY (2015)

Review Biochemistry & Molecular Biology

The emerging role of IncRNAs in cancer

Maite Huarte

NATURE MEDICINE (2015)